Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects
about
Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.The regulation of gastric acid secretion - clinical perspectives.Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist.
P2860
Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Effect of repeated doses of ne ...... nd gastrin in healthy subjects
@en
Effect of repeated doses of ne ...... d gastrin in healthy subjects.
@nl
type
label
Effect of repeated doses of ne ...... nd gastrin in healthy subjects
@en
Effect of repeated doses of ne ...... d gastrin in healthy subjects.
@nl
prefLabel
Effect of repeated doses of ne ...... nd gastrin in healthy subjects
@en
Effect of repeated doses of ne ...... d gastrin in healthy subjects.
@nl
P2860
P356
P1476
Effect of repeated doses of ne ...... nd gastrin in healthy subjects
@en
P2093
Steve Warrington
P2860
P304
P356
10.1111/BCP.12095
P407
P577
2013-11-01T00:00:00Z